One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dementia therapy: time for an energy boost
doi : 10.1093/brain/awae120
Volume 147, Issue 5, May 2024
Lucretius and the neural consequences of traumatic amputation: the role of descending inhibition?
doi : 10.1093/brain/awae087
Blood GFAP reflects astrocyte reactivity to Alzheimer’s pathology in post-mortem brain tissue
doi : 10.1093/brain/awae104
More than 185 CAG repeats: a point of no return in Huntington’s disease biology
doi : 10.1093/brain/awae105
Vaccination with structurally modified fungal protein fibrils: a new treatment for synucleinopathies?
doi : 10.1093/brain/awae115
How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?
doi : 10.1093/brain/awae039
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development
doi : 10.1093/brain/awae028
Engineered Wnt7a ligands rescue blood–brain barrier and cognitive deficits in a COVID-19 mouse model
doi : 10.1093/brain/awae031
Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease
doi : 10.1093/brain/awae061
L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized study
doi : 10.1093/brain/awae041
Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
doi : 10.1093/brain/awae035
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains
doi : 10.1093/brain/awad398
Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia
doi : 10.1093/brain/awae016
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
doi : 10.1093/brain/awad432
Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration
doi : 10.1093/brain/awae075
Skin innervation across amyotrophic lateral sclerosis clinical stages: new prognostic biomarkers
doi : 10.1093/brain/awad426
Biallelic BORCS8 variants cause an infantile-onset neurodegenerative disorder with altered lysosome dynamics
doi : 10.1093/brain/awad427
The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis
doi : 10.1093/brain/awad410
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
doi : 10.1093/brain/awae063
Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson’s disease
doi : 10.1093/brain/awad420
Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome
doi : 10.1093/brain/awae010
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes
doi : 10.1093/brain/awad403
Increased expression of chondroitin sulfate proteoglycans in dentate gyrus and amygdala causes postinfectious seizures
doi : 10.1093/brain/awad430
p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions
doi : 10.1093/brain/awad421
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease
doi : 10.1093/brain/awad436
Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation
doi : 10.1093/brain/awae018
Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children
doi : 10.1093/brain/awae005
Follow the allosteric transitions to predict variant pathogenicity: a channel-specific approach
doi : 10.1093/brain/awae008
Reply: Follow the allosteric transitions to predict variant pathogenicity: a channel-specific approach
doi : 10.1093/brain/awae009
Higher than expected incident cases of spinal bulbar muscular atrophy in western Canada
doi : 10.1093/brain/awae052
